Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study
Fendler, A.; Au, L.; Boos, L. A.; Byrne, F.; Shepherd, S. T. C.; Shum, B.; Gerard, C. L.; Ward, B.; Xie, W.; Cerrone, M.; Cornish, G. H.; Pule, M.; Mekkaoui, L.; Ng, K.; Stone, R.; Gomes, C.; Flynn, H. R.; Agua-Doce, A.; Hobson, P.; Caidan, S.; Howell, M.; Goldstone, R.; Gavrielides, M.; Nye, E.; Snijders, B.; Macrae, J.; Nicod, J.; Hayday, A.; Gronthoud, F.; Messiou, C.; Cunningham, D.; Chau, I.; Starling, N.; Turner, N.; Rusby, J.; Welsh, L.; van As, N.; Jones, R.; Droney, J.; Banerjee, S.; Tatham, K.; Jhanji, S.; O'Brien, M.; Curtis, O.; Harrington, K.; Bhide, S.; Slattery, T.; Khan, Y.; Ti
Show abstract
There is a pressing need to characterise the nature, extent and duration of immune response to SARS-CoV-2 in cancer patients and inform risk-reduction strategies and preserve cancer outcomes. CAPTURE is a prospective, longitudinal cohort study of cancer patients and healthcare workers (HCWs) integrating longitudinal immune profiling and clinical annotation. We evaluated 529 blood samples and 1051 oronasopharyngeal swabs from 144 cancer patients and 73 HCWs and correlated with >200 clinical variables. In patients with solid cancers and HCWs, S1-reactive and neutralising antibodies to SARS-CoV-2 were detectable five months post-infection. SARS-CoV-2-specific T-cell responses were detected, and CD4+ T-cell responses correlated with S1 antibody levels. Patients with haematological malignancies had impaired but partially compensated immune responses. Overall, cancer stage, disease status, and therapies did not correlate with immune responses. These findings have implications for understanding individual risks and potential effectiveness of SARS-CoV-2 vaccination in the cancer population.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer 95%
- High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer 94%
- Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma 94%
Similar papers in this journal
- Tissue-resident NK cells support survival in pancreatic cancer through promotion of cDC1-CD8T activity 94%
- Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. 94%
- Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy 93%
Similar papers in this journal
- Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses 94%
- The CD8+ T cell landscape of human brain metastases 94%
- Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells 94%
Similar papers in this journal
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 94%
- Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent but clinically inapparent in cancer patients under immune checkpoint therapy 93%
- Metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.